14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

CTRV Predictions History

7 years ago
Adrian predicted that CTRV for 2017-04-06 is going $1.62 (-99.82%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that CTRV for 2017-04-06 is going $1.73 (-99.81%)

7 years ago
JS predicted that CTRV for 2017-04-05 is going $1.78 (-99.80%)

7 years ago
Adrian predicted that CTRV for 2017-04-05 is going $1.75 (-99.82%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that CTRV for 2017-04-05 is going $1.75 (-99.82%)

7 years ago
Adrian predicted that CTRV for 2017-04-04 is going $1.94 (-99.81%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that CTRV for 2017-04-04 is going $1.71 (-99.83%)

7 years ago
JS predicted that CTRV for 2017-03-31 is going $1.76 (-99.82%)

7 years ago
Ben.Worley.4355 predicted that CTRV for 2017-03-31 is going $1.80 (-99.82%)

Rank:

7 years ago
mhmd predicted that CTRV for 2017-03-30 is going $1.11 (-99.88%)

Rank:
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT